Dr
Jamie
Thomson

Partner & Patent Attorney

Edinburgh Office Glasgow Office

Chemistry

Telephone. 44(0) 131 220 7500
Mobile. +44(0) 771 748 3525
Email. [email protected]

Experience

Jamie has over 20 years’ experience in the patent profession, working both in private practise and in-house. He specialises in the field of chemistry, particularly medical devices, pharmaceuticals and performance chemicals.

As well as drafting and prosecuting patent applications and managing global patent portfolios, he handles contentious EPO opposition and appeal proceedings having gained significant experience whilst living and working in Munich. Jamie also provides strategic advice on IP portfolios, and opinions on the infringement and validity of patents.

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

B. Sc. (Hons) Chemistry, First Class, University of St Andrews

PHD

Ph. D. (Chemistry), University of St Andrews

Recognition

MIP Patent Star

View recognition online

IAM Patent 1000

"In Edinburgh, Jamie Thomson manages global patent portfolios in the fields of medical devices, pharmaceuticals and performance chemicals. He is also no stranger to oppositions and appeals at the EPO, having gained abundant experience in the area over two years stationed in Munich."

View recognition online

Publications

IAM Patent 1000 2022

View publication online

IAM Patent 1000 2020

View publication online

MIP IP Stars 2020

View publication online

IAM Patent 1000 2019

View publication online

HGF awarded 'Winner of the Prosecution Firm of the year' UK (Scotland) 2019 at the Managing IP - Global IP awards

View publication online

CSR

Jamie sits on the Law Society of Scotland’s IP sub-committee, which reviews new IP legislation effecting Scotland.

Related News

Event - 21st-22nd September 2022

Medical Technology Ireland 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource. Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to …

Event details

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.